Amylyx Pharmaceuticals (AMLX) Shares Issued (2021 - 2025)
Historic Shares Issued for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $2.7 million.
- Amylyx Pharmaceuticals' Shares Issued rose 44154.79% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 6512.23%. This contributed to the annual value of $2.1 million for FY2024, which is 6951.67% down from last year.
- As of Q3 2025, Amylyx Pharmaceuticals' Shares Issued stood at $2.7 million, which was up 44154.79% from $72000.0 recorded in Q2 2025.
- In the past 5 years, Amylyx Pharmaceuticals' Shares Issued ranged from a high of $200.9 million in Q1 2022 and a low of $3000.0 during Q2 2021
- Its 5-year average for Shares Issued is $13.4 million, with a median of $419000.0 in 2023.
- Per our database at Business Quant, Amylyx Pharmaceuticals' Shares Issued skyrocketed by 64795483.87% in 2022 and then tumbled by 9823.84% in 2023.
- Over the past 5 years, Amylyx Pharmaceuticals' Shares Issued (Quarter) stood at $145000.0 in 2021, then surged by 138449.66% to $200.9 million in 2022, then plummeted by 99.83% to $347000.0 in 2023, then plummeted by 57.35% to $148000.0 in 2024, then surged by 1696.62% to $2.7 million in 2025.
- Its Shares Issued was $2.7 million in Q3 2025, compared to $72000.0 in Q2 2025 and $970000.0 in Q1 2025.